166 related articles for article (PubMed ID: 21114560)
1. Ciclosporin A therapy is associated with disturbances in glucose metabolism in dogs with atopic dermatitis.
Kovalik M; Thoday KL; Handel IG; Bronsvoort BM; Evans H; van den Broek AH; Mellanby RJ
Vet Dermatol; 2011 Apr; 22(2):173-80. PubMed ID: 21114560
[TBL] [Abstract][Full Text] [Related]
2. Prednisolone is associated with an increase in serum insulin but not serum fructosamine concentrations in dogs with atopic dermatitis.
Kovalik M; Thoday KL; Evans H; van den Broek AH; Mellanby RJ
Vet J; 2012 May; 192(2):212-6. PubMed ID: 21745752
[TBL] [Abstract][Full Text] [Related]
3. Long-term use of cyclosporine in the treatment of canine atopic dermatitis.
Radowicz SN; Power HT
Vet Dermatol; 2005 Apr; 16(2):81-6. PubMed ID: 15842537
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A pharmacokinetics and efficacy in the treatment of atopic dermatitis in dogs.
Steffan J; Strehlau G; Maurer M; Rohlfs A
J Vet Pharmacol Ther; 2004 Aug; 27(4):231-8. PubMed ID: 15305852
[TBL] [Abstract][Full Text] [Related]
5. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
6. Zinc-carnosine and vitamin E supplementation does not ameliorate gastrointestinal side effects associated with ciclosporin therapy of canine atopic dermatitis.
Wilson LS; Rosenkrantz WS; Roycroft LM
Vet Dermatol; 2011 Feb; 22(1):53-60. PubMed ID: 20586994
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine decreases skin lesions and pruritus in dogs with atopic dermatitis: a blinded randomized prednisolone-controlled trial.
Olivry T; Rivierre C; Jackson HA; Murphy KM; Davidson G; Sousa CA
Vet Dermatol; 2002 Apr; 13(2):77-87. PubMed ID: 11972891
[TBL] [Abstract][Full Text] [Related]
8. Ciclosporin therapy is associated with minimal changes in calcium metabolism in dogs with atopic dermatitis.
Kovalik M; Mellanby RJ; Evans H; Berry J; van den Broek AH; Thoday KL
Vet Dermatol; 2012 Dec; 23(6):481-e91. PubMed ID: 23140314
[TBL] [Abstract][Full Text] [Related]
9. Relationship of body weight to maintenance cyclosporine a dose in canine atopic dermatitis.
Cohen L; Zabel S; Rosychuk RA
J Am Anim Hosp Assoc; 2014; 50(3):174-80. PubMed ID: 24659725
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a human generic formulation of ciclosporin in the treatment of canine atopic dermatitis with in vitro assessment of the functional capacity of phagocytic cells.
Kovalik M; Taszkun I; Pomorski Z; Kozak M; Pomorska D; Szczepanik M; Wilkolek P; Palenik L; Shaw DJ; van den Broek AH; Thoday KL
Vet Rec; 2011 May; 168(20):537. PubMed ID: 21558130
[TBL] [Abstract][Full Text] [Related]
11. Favorable clinical response by pre-prandial administration of low-dose ciclosporin to severe adult atopic dermatitis.
Nakamura S; Takeda K; Hashimoto Y; Nishi K; Takahashi H; Mizumoto T; Iizuka H
J Dermatolog Treat; 2012 Apr; 23(2):112-5. PubMed ID: 21254847
[TBL] [Abstract][Full Text] [Related]
12. Influence of food intake on the clinical response to cyclosporin A in canine atopic dermatitis.
Thelen A; Mueller RS; Linek M; Peters S; Stechmann K; Steffan J
Vet Rec; 2006 Dec; 159(25):854-6. PubMed ID: 17172483
[No Abstract] [Full Text] [Related]
13. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
14. A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs.
Little PR; King VL; Davis KR; Cosgrove SB; Stegemann MR
Vet Dermatol; 2015 Feb; 26(1):23-30, e7-8. PubMed ID: 25496303
[TBL] [Abstract][Full Text] [Related]
15. Investigation on the effects of ciclosporin (Atopica) on intradermal test reactivity and allergen-specific immunoglobulin (IgE) serology in atopic dogs.
Goldman C; Rosser E; Petersen A; Hauptman J
Vet Dermatol; 2010 Aug; 21(4):393-9. PubMed ID: 20214766
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous nocardiosis in two dogs receiving ciclosporin therapy for the management of canine atopic dermatitis.
Siak MK; Burrows AK
Vet Dermatol; 2013 Aug; 24(4):453-6, e102-3. PubMed ID: 23781943
[TBL] [Abstract][Full Text] [Related]
17. Long-term cyclosporine treatment in non-transplanted rats and metabolic risk factors of vascular diseases.
Böhmer AE; Souza DG; Hansel G; Brum LM; Portela LV; Souza DO
Chem Biol Interact; 2010 Apr; 185(1):53-8. PubMed ID: 20188083
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a new topical cyclosporine A formulation in the treatment of atopic dermatitis in dogs.
Puigdemont A; Brazís P; Ordeix L; Dalmau A; Fuertes E; Olivar A; Pérez C; Ravera I
Vet J; 2013 Aug; 197(2):280-5. PubMed ID: 23562341
[TBL] [Abstract][Full Text] [Related]
19. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.
Bensignor E; Olivry T
Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106
[TBL] [Abstract][Full Text] [Related]
20. A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs.
Steffan J; Favrot C; Mueller R
Vet Dermatol; 2006 Feb; 17(1):3-16. PubMed ID: 16412115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]